Aviva FY Adj. Operating Profit From Cont. Ops. Declines

Aviva PLC (AV.L,AV) reported fiscal year adjusted operating profit from continuing operations of 1.63 billion pounds, down 10 percent from prior year. The Group also announced a total capital return to shareholders of 4.75 billion pounds, including the existing 1 billion pounds share buyback.

Fiscal year profit before tax from continuing operations declined to 801 million pounds from 1.81 billion pounds, last year. Earnings per share from continuing operations was 7.6 pence compared to 35.5 pence.

For the year ended 31 December 2021, net earned premiums was 14.39 billion pounds compared to 14.99 billion pounds, previous year.

The Board of Directors has declared a final dividend of 14.7 pence, bringing Aviva's 2021 total dividend per share to 22.05 pence, up 5% versus 2020.

For 2022, the Group estimates to pay a dividend of per share amount of approximately 31.5 pence, an increase of approximately 40% on 2021.

For 2023, the Group estimates to pay a cash dividend per share of around 33 pence.

Beyond 2023, the Group projects low-to-mid single digit growth in dividends per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT